Biogen Inc Stock Current Valuation
IDP Stock | EUR 199.15 1.85 0.92% |
Valuation analysis of Biogen Inc helps investors to measure Biogen's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Biogen's price fluctuation is very steady at this time. Calculation of the real value of Biogen Inc is based on 3 months time horizon. Increasing Biogen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Biogen Inc is useful when determining the fair value of the Biogen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Biogen. Since Biogen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biogen Stock. However, Biogen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 199.15 | Real 168.37 | Hype 199.15 | Naive 210.61 |
The real value of Biogen Stock, also known as its intrinsic value, is the underlying worth of Biogen Inc Company, which is reflected in its stock price. It is based on Biogen's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Biogen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biogen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biogen Inc helps investors to forecast how Biogen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biogen more accurately as focusing exclusively on Biogen's fundamentals will not take into account other important factors: Biogen Inc Company Current Valuation Analysis
Biogen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Biogen Current Valuation | 41.13 B |
Most of Biogen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biogen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Biogen Inc has a Current Valuation of 41.13 B. This is 186.32% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all Germany stocks is 147.38% lower than that of the firm.
Biogen Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biogen's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biogen could also be used in its relative valuation, which is a method of valuing Biogen by comparing valuation metrics of similar companies.Biogen is currently under evaluation in current valuation category among related companies.
Biogen Fundamentals
Return On Equity | 0.24 | |||
Return On Asset | 0.0778 | |||
Profit Margin | 0.30 % | |||
Operating Margin | 0.30 % | |||
Current Valuation | 41.13 B | |||
Shares Outstanding | 144.49 M | |||
Shares Owned By Insiders | 0.68 % | |||
Shares Owned By Institutions | 89.93 % | |||
Price To Earning | 14.27 X | |||
Price To Book | 3.24 X | |||
Price To Sales | 3.84 X | |||
Revenue | 10.17 B | |||
Gross Profit | 7.9 B | |||
EBITDA | 4.36 B | |||
Net Income | 3.05 B | |||
Cash And Equivalents | 2.54 B | |||
Cash Per Share | 16.85 X | |||
Total Debt | 6.28 B | |||
Debt To Equity | 0.72 % | |||
Current Ratio | 2.12 X | |||
Book Value Per Share | 92.98 X | |||
Cash Flow From Operations | 1.38 B | |||
Earnings Per Share | 19.22 X | |||
Price To Earnings To Growth | 36.01 X | |||
Target Price | 413.19 | |||
Number Of Employees | 8.72 K | |||
Beta | 0.22 | |||
Market Capitalization | 36.91 B | |||
Total Asset | 24.55 B | |||
Z Score | 3.0 | |||
Net Asset | 24.55 B |
About Biogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies |